Category: medical marijuana

Study: Majority Of Chronic Pain Patients Replace Opioids With Cannabis

More than two-thirds of chronic pain patients registered to legally access medical cannabis products substitute marijuana for prescription opioids, according to data published in The Journal of Headache and Pain Among those patients diagnosed specifically with headache/migraine, cannabis was frequently reported as a substitute for other medications – including opiates (43 percent), anti-depressants (39 percent), NSAIDS (21 percent), triptans (8 percent), and anti-convulsants (8 percent).

Florida: Court Strikes Down Legislative Ban On Medical Cannabis Smoking

A Florida Circuit Court judge ruled today that a legislatively enacted ban on the smoking of medical cannabis in private by qualified patients is unconstitutional. “Section 381.986, Florida Statutes (2017) unconstitutionally restricts rights that are protected in the Constitution, and so the statutory prohibition against the use of smokeable marijuana permitted by [a] qualifying patient is declared invalid and unenforceable,” the judge ruled.

Arizona: Supreme Court Affirms That Lawmakers Cannot Ban Medical Cannabis Access on College Campuses

In a ruling issued today by the Arizona Supreme Court, justices upheld an appellate court decision striking down a 2012 law that sought to forbid medical cannabis access on college campuses. Lifetime NORML Legal Committee member Tom Dean represented the patient-defendant in the case pro bono, and called the decision a “victory for democracy.”

Missouri Medical Marijuana Initiative Filed

Board members and activists with New Approach Missouri, a campaign to legalize medical marijuana, submitted more 370,000 signatures to place the legalization of medical access to marijuana for therapeutic purposes on the ballot in Missouri in November of 2018.

Legislation Introduced To End The Federal Government’s Marijuana Production Monopoly

A bipartisan coalition of over two-dozen federal lawmakers, including House Judiciary Chairman Bob Goodlatte (R-VA) and Matt Gaetz (R-FL), are backing newly introduced legislation — The Medical Cannabis Research Act of 2018 — to facilitate federally-approved clinical trials involving cannabis. Passage of this act would end the University of Mississippi’s existing monopoly on the growth of cannabis for clinical research purposes by requiring the licensing of additional manufacturers.